- Home
- RLAY vs PEO Comparison
RLAY vs PEO Comparison
Compare RLAY & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- PEO
- Stock Information
- Founded
- RLAY 2015
- PEO 1929
- Country
- RLAY United States
- PEO United States
- Employees
- RLAY N/A
- PEO N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- PEO Finance/Investors Services
- Sector
- RLAY Health Care
- PEO Finance
- Exchange
- RLAY Nasdaq
- PEO Nasdaq
- Market Cap
- RLAY 723.1M
- PEO 596.4M
- IPO Year
- RLAY 2020
- PEO N/A
- Fundamental
- Price
- RLAY $4.94
- PEO $23.55
- Analyst Decision
- RLAY Strong Buy
- PEO
- Analyst Count
- RLAY 10
- PEO 0
- Target Price
- RLAY $20.11
- PEO N/A
- AVG Volume (30 Days)
- RLAY 2.9M
- PEO 35.4K
- Earning Date
- RLAY 02-20-2025
- PEO 01-01-0001
- Dividend Yield
- RLAY N/A
- PEO 5.93%
- EPS Growth
- RLAY N/A
- PEO N/A
- EPS
- RLAY N/A
- PEO N/A
- Revenue
- RLAY $10,006,000.00
- PEO N/A
- Revenue This Year
- RLAY N/A
- PEO N/A
- Revenue Next Year
- RLAY N/A
- PEO N/A
- P/E Ratio
- RLAY N/A
- PEO N/A
- Revenue Growth
- RLAY N/A
- PEO N/A
- 52 Week Low
- RLAY $3.50
- PEO $19.22
- 52 Week High
- RLAY $11.16
- PEO $23.80
- Technical
- Relative Strength Index (RSI)
- RLAY 53.29
- PEO 66.34
- Support Level
- RLAY $3.50
- PEO $23.30
- Resistance Level
- RLAY $5.99
- PEO $23.97
- Average True Range (ATR)
- RLAY 0.54
- PEO 0.34
- MACD
- RLAY 0.06
- PEO 0.23
- Stochastic Oscillator
- RLAY 49.40
- PEO 87.04
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PEO Adams Natural Resources Fund Inc.
Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.